NBD AI Bulletin -- Zhejiang Huahai Pharmaceutical Co., Ltd (SH 600521, close price: 18.79 yuan) on April 10 announced that the Company's shareholder Du Jun reduced 170,000 shares in the Company from January 10, 2022 to April 10, 2022, accounting for 0.0114% of the Company's total equity. And the time for the stock reduction plan has been halfway through.

Zhejiang Huahai Pharmaceutical Co Ltd's chairman is Li Hong, male, with an undergraduate degree, the general manager is Chen Baohua, male, 60 years old, with an undergraduate degree.

(By Gao Han)

Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.